MaxCyte, Inc. (MXCT) Free cash flow 2019–2025
MaxCyte, Inc. (MXCT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$36.2MFY2025 · since FY2019: -$10.1M → -$36.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$36.2M | -23.6% |
| FY2024 | -$29.3M | -15.3% |
| FY2023 | -$25.4M | +23.7% |
| FY2022 | -$33.3M | -129.2% |
| FY2021 | -$14.5M | -33.7% |
| FY2020 | -$10.9M | -7.7% |
| FY2019 | -$10.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice